You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cefizox In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Cefizox In Dextrose 5% In Plastic Container is a drug marketed by Astellas and is included in one NDA.

The generic ingredient in CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
DailyMed Link:CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed
Drug patent expirations by year for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ministry of Health, SudanPhase 4
University of KhartoumPhase 4

See all CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-001 Oct 3, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-002 Oct 3, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.